Cargando…

Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer

Detalles Bibliográficos
Autores principales:	Chebel, Roy, Labaki, Chris, Farhat, Maria, Kattan, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246498/ https://www.ncbi.nlm.nih.gov/pubmed/34249141 http://dx.doi.org/10.2217/fvl-2021-0072

Ejemplares similares

Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Vaccination for SARS-CoV-2 of migrants and refugees, Jordan
por: Bellizzi, Saverio, et al.
Publicado: (2021)

In Pursuit of a SARS-CoV-2 Vaccine
por: Johnson, Alton R., et al.
Publicado: (2020)

SARS-CoV2 vaccines: Slow is fast
por: Green, Douglas R.
Publicado: (2020)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

SARS-CoV2 vaccine boosters for India
por: Kang, Gagandeep
Publicado: (2022)

The SARS-CoV-2 vaccines: Retrospective and perspectives
por: Epaulard, Olivier
Publicado: (2022)

Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey
por: Moujaess, Elissar, et al.
Publicado: (2021)

A vaccine for SARS-CoV-2: goals and promises
Publicado: (2020)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

SARS-CoV-2 Vaccination for Children—An Open Issue
por: Caselli, Désirée, et al.
Publicado: (2021)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead
por: Baldo, Vincenzo, et al.
Publicado: (2021)

Influenza vaccination in the time of SARS-CoV-2()
por: Reina, Jordi
Publicado: (2021)

SARS‐CoV‐2 vaccine clinical efficacy in SOT: What we know and our current gaps
por: Sigler, Rachel, et al.
Publicado: (2022)

Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis
por: Zhan, Haoting, et al.
Publicado: (2023)

Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
por: Kremer, Eric J.
Publicado: (2020)

The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
por: Morris, Kevin V.
Publicado: (2020)

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2021)

Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021)

Commentary on ‘Will vaccination refusal prolong the war on SARS-CoV-2?’
por: Welsby, Philip D
Publicado: (2020)

Vaccination against SARS-CoV-2 should be included in childhood vaccination programs
por: Petersen, Eskild, et al.
Publicado: (2021)

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
por: Mascellino, Maria Teresa, et al.
Publicado: (2021)

Maintaining Safety with SARS-CoV-2 Vaccines
por: Castells, Mariana C., et al.
Publicado: (2020)

Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis()
por: Callejas Rubio, José Luis, et al.
Publicado: (2022)

Safety and Efficacy of SARS-CoV-2 Vaccination in Patients with Chronic Liver Disease
por: Mao, Yu-Feng, et al.
Publicado: (2023)

In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2
por: Felfeli, Tina, et al.
Publicado: (2021)

A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
por: Chavda, Vivek P, et al.
Publicado: (2021)

Can an effective SARS-CoV-2 vaccine be developed for the older population?
por: Pawelec, Graham, et al.
Publicado: (2020)

Realising the potential of SARS-CoV-2 vaccines—a long shot?
por: The Lancet Respiratory Medicine
Publicado: (2021)

SARS-CoV-2 Vaccination — An Ounce (Actually, Much Less) of Prevention
por: Rubin, Eric J., et al.
Publicado: (2020)

Impact of spike genetic variants in vaccines against SARS-CoV-2()
por: Reina, J., et al.
Publicado: (2021)

Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
por: Parums, Dinah V.
Publicado: (2021)

SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?
por: Krueger, Karen M., et al.
Publicado: (2022)

SARS-CoV-2 vaccination should be required to practise medicine in Canada
por: McRae, Andrew D., et al.
Publicado: (2021)

SARS-CoV-2 Vaccination: What Can We Expect Now?
por: Meurens, François, et al.
Publicado: (2022)

A Brief Focus on SARS-CoV-2 Genomic Evolution and Vaccines
por: Pratelli, Annamaria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ta88dvlue2dn8n905u90einrr5